Literature DB >> 18655776

Mutational study of the "catalytic tetrad" of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: Role of Asp-353 and Asn-221 in camptothecin resistance.

Rosario Diaz-González1, Yolanda Pérez-Pertejo, Yves Pommier, Rafael Balaña-Fouce, Rosa M Reguera.   

Abstract

Leishmania donovani, the causative organism for visceral leishmaniasis, contains a unique bisubunit DNA-topoisomerase IB (LdTopIB). The catalytically active enzyme is a heterodimer constituted by a large subunit (LdTopIL) containing a non-conserved N-terminal end and the phylogenetically conserved core domain, whereas the small subunit (LdTopIS) harbors the C-terminal domain with the characteristic tyrosine residue in the active site. Site-directed mutagenesis was used to substitute the basic amino acid (Arg-314, Lys-352, Arg-410 and His-453) of the LdTopIL subunit by the neutral amino acid alanine. The expression of these mutants in a topoisomerase-free yeast strain produced inactive proteins. Similarly, when the Tyr-222 from small subunit, involved in DNA cleavage, was substituted by Phe no topoisomerase activity was detected in yeast overexpressing extracts. In addition two substitutions involved in camptothecin inhibition were also analyzed. Asp-353 located in the core domain of the large subunit and Asn-221 which heads Tyr-222 in the small subunit, were replaced by Ala and Ser, respectively. These mutants were insensitive to the inhibitor; despite they displayed significant relaxation activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18655776      PMCID: PMC9103752          DOI: 10.1016/j.bcp.2008.06.019

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   6.100


  39 in total

1.  Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I.

Authors:  Paola Fiorani; Alessandro Bruselles; Mattia Falconi; Giovanni Chillemi; Alessandro Desideri; Piero Benedetti
Journal:  J Biol Chem       Date:  2003-08-06       Impact factor: 5.157

Review 2.  The pharmacology of leishmaniasis.

Authors:  R Balaña-Fouce; R M Reguera; J C Cubría; D Ordóñez
Journal:  Gen Pharmacol       Date:  1998-04

Review 3.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

4.  Topoisomerase I amino acid substitutions, Gly185Arg and Asp325Glu, confer camptothecin resistance in Leishmania donovani.

Authors:  Jean-François Marquis; Isabelle Hardy; Martin Olivier
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.

Authors:  Y Urasaki; G Laco; Y Takebayashi; C Bailly; G Kohlhagen; Y Pommier
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

6.  Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I.

Authors:  R M Lynn; M A Bjornsti; P R Caron; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  The role of lysine 532 in the catalytic mechanism of human topoisomerase I.

Authors:  Heidrun Interthal; Paulene M Quigley; Wim G J Hol; James J Champoux
Journal:  J Biol Chem       Date:  2003-10-31       Impact factor: 5.157

8.  Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants.

Authors:  A M Knab; J Fertala; M A Bjornsti
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

9.  The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA.

Authors:  Douglas R Davies; Adeel Mushtaq; Heidrun Interthal; James J Champoux; Wim G J Hol
Journal:  J Mol Biol       Date:  2006-01-26       Impact factor: 5.469

10.  Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania.

Authors:  A L Bodley; T A Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

View more
  7 in total

1.  First total synthesis and antileishmanial activity of (Z)-16-methyl-11-heptadecenoic acid, a new marine fatty acid from the sponge Dragmaxia undata.

Authors:  Néstor M Carballeira; Nashbly Montano; Gabriel A Cintrón; Carmary Márquez; Celia Fernández Rubio; Christopher Fernández Prada; Rafael Balaña-Fouce
Journal:  Chem Phys Lipids       Date:  2010-12-01       Impact factor: 3.329

2.  Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan.

Authors:  Chloé Rosa-Teijeiro; Victoria Wagner; Audrey Corbeil; Ilda d'Annessa; Philippe Leprohon; Rubens L do Monte-Neto; Christopher Fernandez-Prada
Journal:  Parasit Vectors       Date:  2021-08-28       Impact factor: 3.876

3.  Total synthesis and antileishmanial activity of the natural occurring acetylenic fatty acids 6-heptadecynoic acid and 6-icosynoic acid.

Authors:  Néstor M Carballeira; Michelle M Cartagena; Christopher Fernández Prada; Celia Fernández Rubio; Rafael Balaña-Fouce
Journal:  Lipids       Date:  2009-09-30       Impact factor: 1.880

4.  Indotecan (LMP400) and AM13-55: two novel indenoisoquinolines show potential for treating visceral leishmaniasis.

Authors:  Rafael Balaña-Fouce; Christopher F Prada; José María Requena; Mark Cushman; Yves Pommier; Raquel Álvarez-Velilla; José Miguel Escudero-Martínez; Estefania Calvo-Álvarez; Yolanda Pérez-Pertejo; Rosa M Reguera
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

5.  First total synthesis and antiprotozoal activity of (Z)-17-methyl-13-octadecenoic acid, a new marine fatty acid from the sponge Polymastia penicillus.

Authors:  Néstor M Carballeira; Nashbly Montano; Rafael Balaña-Fouce; Christopher Fernández Prada
Journal:  Chem Phys Lipids       Date:  2009-06-13       Impact factor: 3.329

6.  Identification and characterization of the regions involved in the nuclear translocation of the heterodimeric leishmanial DNA topoisomerase IB.

Authors:  Christopher F Prada; Raquel Álvarez-Velilla; Rosario Díaz-Gozález; Yolanda Pérez-Pertejo; Rafael Balaña-Fouce; Rosa M Reguera
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

Review 7.  Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.

Authors:  Rafael Balaña-Fouce; Raquel Alvarez-Velilla; Christopher Fernández-Prada; Carlos García-Estrada; Rosa M Reguera
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-24       Impact factor: 4.077

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.